Kory Blocker is currently working as an Associate Director in Upstream Process Development at Rocket Pharmaceuticals. Prior to this, Kory held positions at the Gene Therapy Program at the University of Pennsylvania and Thermo Fisher Scientific, where Kory worked on process development for biologics production. Kory has a background in Chemical Engineering, with a PhD from the University of Delaware and a BS from Bucknell University.